Durvalumab vs Menotropins

## Durvalumab vs Menotropins: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Menotropins**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Menotropins — N/A.

## Chemical Properties

**Type**: Durvalumab — Antibody; Menotropins — Protein.